Navigation Links
Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
Date:5/3/2012

GUANGZHOU, China, May 3, 2012 /PRNewswire-Asia/ -- Johnson & Johnson (China) Investment Ltd. today announced it has acquired Guangzhou Bioseal Biotechnology Co., Ltd. (Bioseal) a privately held biopharmaceutical company specializing in the design, development and commercialization of a porcine plasma-derived biologic product for controlling bleeding during surgery. The acquisition was completed after obtaining all necessary Chinese Government approvals. Financial terms of the transaction are not being disclosed.

"This transaction reinforces our commitment to China and delivering innovative medical device solutions to the Chinese market," said Xie Wen Jian President of Johnson & Johnson Medical China. "We are very pleased to add the BIOSEAL™ brand to our growing portfolio of hemostasis products in China and we look forward to working with our new Bioseal colleagues to bring their innovative products to more physicians and patients."

Bioseal manufactures a porcine-derived fibrin sealant, BIOSEAL™, currently the only porcine plasma-derived fibrin sealant approved for use in China. Fibrin sealants are used by surgeons as an adjunct to hemostasis for use in patients undergoing surgery, when control of bleeding by standard surgical techniques is ineffective or impractical.

Bioseal will work closely with Ethicon, Inc., a Johnson & Johnson Company, which offers the world's most complete line of absorbable hemostats with a commitment to advancing the future of biosurgery beyond hemostasis, to seal leaks, join structures and enhance healing. Ethicon biosurgery brands already on the market in China include SURGICEL® and SURGIFLO®.

"By adding Bioseal to the existing line of Ethicon hemostasis products sold in China, we aspire to shape the broader biosurgery market in Asia by providing physicians and their patients with an even greater variety of innovative and clinical-based solutions to add
'/>"/>

SOURCE Johnson & Johnson (China) Investment Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Johnson & Johnson to Provide Webcast Presentation of XARELTO® (rivaroxaban) Phase 3 Clinical Data Presented at the American College of Cardiologys Annual Scientific Sessions
2. CNJ Enterprises: DePuy ASR Hip Implant Recall Large Contributor to Johnson & Johnsons $2.9 Bil Charge for 4th Quarter 2011
3. Johnson & Johnson Reports 2011 Fourth-Quarter and Full-Year Results:
4. Johnson & Johnson to Host Analyst Meeting to Discuss Fourth-Quarter and Full-Year 2011 Financial Results
5. Johnson & Johnson to Participate in the Piper Jaffray 23rd Annual Health Care Conference
6. Johnson & Johnson Reports 2011 Third-Quarter Results
7. Johnson & Johnson to Host Analyst Conference Call on Third-Quarter Results
8. Boston Scientific Announces Favorable Appellate Court Ruling Affirming Non-Infringement of Johnson & Johnson Patent
9. McNEIL-PPC, Inc. Acquires Full Ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals Co. Joint Venture
10. Johnson & Johnson Makes Strong Progress in First Year of Initiative to Improve Health of Millions of Women and Children in the Developing World
11. Johnson & Johnson to Participate in Morgan Stanley Global Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... -- Prismic Pharmaceuticals, Inc., a specialty pharmaceutical company developing ... the election of Joseph J. Krivulka and ... Directors. Commenting on the election of these ... and CEO of Prismic, stated, "We are delighted that ... have accepted our invitation to join Prismic,s Board of ...
(Date:7/1/2015)... , July 1, 2015 Dynatronics Corporation ... and marketer of rehabilitation and physical therapy products, ... private placement financing led by affiliates of Prettybrook ... investor focused on the healthcare industry. The financing ... growth and pursue potential strategic acquisitions.  ...
(Date:7/1/2015)... SHANGHAI , July 1, 2015 Qiming ... Hu to Managing Partner effective immediately. ... He has lead and participated in many Qiming healthcare ... leaders in the Chinese market. Qiming, s success in ... and he has distinguished himself with his outstanding advocacy ...
Breaking Medicine Technology:Joseph Krivulka and Martin Simonetti Join Board of Prismic Pharmaceuticals 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 3Qiming Announces the Promotion of William Hu to Managing Partner 2
... May 8, 2012  In a little more than ... Services Organization ( CalHIPSO ) has successfully developed ... throughout California implement Electronic Health Records (EHRs), considered ... of healthcare. This and other key milestones are ...
... A team of scientists led by Dr. Stanley Fricke of ... "Magnetic resonance imaging (MRI) sound barrier," a finding that could ... a new clinical study published this week in the peer-reviewed ... ultimate goal," said Dr. Fricke, "is to image small children ...
Cached Medicine Technology:CalHIPSO Enrolls Over 7,700 Providers in EHR Implementation Program, Hits Other Key Milestones After First Two Years 2Children's National Medical Center Breaks MRI Speed Sound Barrier 2
(Date:7/1/2015)... ... ... Dr. Surya Challa of Chesapeake Vein Center and MedSpa in Chesapeake, VA ... discuss non-invasive CoolSculpting . On the show, Dr. Challa will explain how CoolSculpting ... utilizes Cryolipolysis to literally freeze stubborn, unwanted fat away and give patients the slim, ...
(Date:7/1/2015)... ... 2015 , ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. ... Symposium . Set for March 6th - 8th, the 2016 meeting will be held ... training and fundamentals of nasal surgery through the most modern advancements and updates in ...
(Date:7/1/2015)... NY (PRWEB) , ... July 01, 2015 , ... Summer ... taboo with teenagers to fix noses and chins with plastic surgery when they’re looking ... Surgeons (ASPS) more than 236,000 cosmetic procedures were performed on patients ages 19 and ...
(Date:7/1/2015)... ... July 01, 2015 , ... Did you know that infertility in ... Month, and we at Advanced Fertility Center of Texas (AFCT) would like to talk ... While infertility is often considered to be a “woman’s issue,” male fertility factors can ...
(Date:7/1/2015)... ... - (PRWEB) July 01, 2015 , ... Lisa Keys, the widow of ... August 15-16th (MSG Keys’ birthday) in memory of her late husband and all of ... recipient of the Bronze Star Medal, died during a Special Forces training exercise in ...
Breaking Medicine News(10 mins):Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 2Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 3Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Top Manhattan Facial Plastic Surgeon Dr. Sam Rizk Comments on Teen Surgery Trends 2Health News:Top Manhattan Facial Plastic Surgeon Dr. Sam Rizk Comments on Teen Surgery Trends 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 2Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 4Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 2Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 3
... Man with Cerebral Palsy to Enjoy Time,with Wife and New ... were,the happy words marking the arrival of little Christopher Sokol. ... at the birth of,their first child, but they anticipated challenges ... became a lot easier for,them, thanks to a donated power ...
... Researchers say finding is ,good news, for postmenopausal ... News) -- Contrary to previous study results, the ... cause impairment of cognitive performance, a new study ... be superior to tamoxifen in preventing breast cancer ...
... University has discovered an entirely new signal path for a ... and growth of cancer cells. This discovery, published in ... an entirely new landscape for research on breast and prostate ... signals from various growth factors is critical for normal fetal ...
... 2, 2008) Today, University Health Network (UHN) ... have three 320-slice CT scanners, as Toronto Western ... most advanced Computer Tomography technology, the 320-slice CT ... help cancer specialists map tumours for treatment in ...
... , Compared to the 2003 guidelines, important new recommendations have ... setting up networks of hospitals with different levels of technology ... service , the selection of primary PCI vs ... both primary PCI and fibrinolytis , secondary prevention ...
... to date examining the impact of positron emission tomography ... recurrent colorectal cancer, researchers found that treatment plans were ... an article in the September issue of The ... conducted at four sites throughout Australia and comprised 191 ...
Cached Medicine News:Health News:The SCOOTER Store Donates Power Wheelchair, Giving New Parents Chance to Be an Active Family 2Health News:Breast Cancer Drug Not Tied to Cognitive Decline: Study 2Health News:New discovery about growth factor can be breakthrough for cancer research 2Health News:UHN becomes a world leader in medical imaging for stroke, cancer and cardiac patients 2Health News:UHN becomes a world leader in medical imaging for stroke, cancer and cardiac patients 3Health News:PET scans lead to treatment changes in majority of colorectal cancer patients 2
The TBS-380 Fluorometer is an economical, sensitive fluorometer designed for quick, easy, and accurate fluorescent measurements....
... capsular bag in cases of damaged or ... for scleral fixation with suture. Robert J. ... recognized from his early experience using the ... need for greater stability when confronted with ...
Liquid, ready-to-use, bar-coded Olympus reagents are convenient, economical easy-to-use and reliable. This is one of 122 tests standardized for use on the Olympus AU400e, AU640e, AU2700, and AU5400 C...
Liquid, ready-to-use, bar-coded Olympus reagents are convenient, economical easy-to-use and reliable. This is one of 122 tests standardized for use on the Olympus AU400e, AU640e, AU2700, and AU5400 C...
Medicine Products: